Triggering Immune System With Nanomaterials for Cancer Immunotherapy

Area of Science:

• Oncology
• Immunology
• Nanotechnology
• Materials Science

Background:

• Cancer remains a leading cause of global mortality and morbidity.
• Cancer immunotherapy has advanced significantly but faces challenges like transient cancer suppression and immune-related adverse reactions.
• Current immunotherapies often lack targeted delivery and precise immune cell activation.

Purpose of the Study:

• To review the advancements in nanoparticle-based cancer immunotherapy.
• To explore how nanomaterials can overcome current immunotherapy limitations.
• To discuss future challenges and prospects in nanomodulated cancer immunotherapy.

Main Methods:

• Review of current literature on nanoparticle applications in cancer immunotherapy.
• Analysis of nanoparticle-based delivery systems for immunogens.
• Examination of nanoparticle-mediated photothermal, photodynamic, nanovaccine, T cell, and bacteria-based immunotherapies.

Main Results:

• Nanoparticle systems demonstrate potential for accurate immunogen delivery and immune cell activation (APCs and effector cells).
• Various nanoparticle-based strategies, including photothermal/photodynamic therapy, nanovaccines, and cell-based therapies, are emerging.
• Nanomaterials offer a novel approach to mitigate immune suppression and adverse reactions associated with conventional immunotherapy.

Conclusions:

• Nanoparticle-based immunotherapy presents a promising strategy to enhance efficacy and safety in cancer treatment.
• Further research into nanomodulatory approaches is crucial for overcoming existing challenges in cancer immunotherapy.
• The integration of nanotechnology holds significant potential for the future of cancer immunomodulatory therapy.